Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001666:Binding Sites, Antibody; D003602:Cytotoxicity, Immunologic; D004727:Endothelium / Q000166:cytology / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D005802:Genes, MHC Class II; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000032:analysis / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis; D007801:Langerhans Cells / Q000276:immunology*; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D009532:Nickel / Q000494:pharmacology; D011247:Pregnancy; D011817:Rabbits; D011948:Receptors, Antigen, T-Cell / Q000187:drug effects; D013601:T-Lymphocytes / Q000276:immunology; D014471:Umbilical Veins / Q000166:cytology* / Q000276:immunology
D000961:Antilymphocyte Serum; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D007376:Interleukin-2; D011948:Receptors, Antigen, T-Cell; C029938:nickel sulfate; D009532:Nickel